160 related articles for article (PubMed ID: 18700792)
1. Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis.
Koehn J; Krapfenbauer K; Huber S; Stein E; Sutter W; Watzinger F; Erovic BM; Thurnher D; Schindler T; Fountoulakis M; Turhani D
J Proteome Res; 2008 Sep; 7(9):3818-29. PubMed ID: 18700792
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma.
Kato H; Uzawa K; Onda T; Kato Y; Saito K; Nakashima D; Ogawara K; Bukawa H; Yokoe H; Tanzawa H
Int J Oncol; 2006 Apr; 28(4):873-81. PubMed ID: 16525636
[TBL] [Abstract][Full Text] [Related]
3. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis.
Turhani D; Krapfenbauer K; Thurnher D; Langen H; Fountoulakis M
Electrophoresis; 2006 Apr; 27(7):1417-23. PubMed ID: 16568407
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
[TBL] [Abstract][Full Text] [Related]
5. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
6. Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis.
Vairaktaris E; Kalokerinos G; Goutzanis L; Spyridonidou S; Vassiliou S; Derka S; Nkenke E; Yapijakis C; Vylliotis A; Lazaris A; Patsouris E
Anticancer Res; 2007; 27(3B):1465-73. PubMed ID: 17595763
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of Cathepsin B in oral squamous cell carcinoma.
Yang X; Wei KJ; Zhang L; Pan HY; Li J; Chen WT; Zhong LP; Zhang ZY
Int J Oral Maxillofac Surg; 2010 Feb; 39(2):174-81. PubMed ID: 20042316
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach.
Koike H; Uzawa K; Nakashima D; Shimada K; Kato Y; Higo M; Kouzu Y; Endo Y; Kasamatsu A; Tanzawa H
Int J Oncol; 2005 Jul; 27(1):59-67. PubMed ID: 15942644
[TBL] [Abstract][Full Text] [Related]
9. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous-cell carcinoma: correlation with lymphovascular invasion and lymph-node metastasis.
Nomura H; Uzawa K; Yamano Y; Fushimi K; Ishigami T; Kouzu Y; Koike H; Siiba M; Bukawa H; Yokoe H; Kubosawa H; Tanzawa H
Hum Pathol; 2009 Jan; 40(1):83-91. PubMed ID: 18789482
[TBL] [Abstract][Full Text] [Related]
13. Correlation between the expression of cyclin A protein and p53 activity in oral squamous cell carcinomas.
Chen Q; Zhou H; Guo W; Samaranayake LP; Zhou M; Li B
Cytobios; 2001; 106(412):87-99. PubMed ID: 11503976
[TBL] [Abstract][Full Text] [Related]
14. A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma.
Mlynarek AM; Balys RL; Su J; Hier MP; Black MJ; Alaoui-Jamali MA
Arch Otolaryngol Head Neck Surg; 2007 Sep; 133(9):910-8. PubMed ID: 17875858
[TBL] [Abstract][Full Text] [Related]
15. Frequent genetic alterations and reduced expression of the Axin1 gene in oral squamous cell carcinoma: involvement in tumor progression and metastasis.
Zhou CX; Gao Y
Oncol Rep; 2007 Jan; 17(1):73-9. PubMed ID: 17143481
[TBL] [Abstract][Full Text] [Related]
16. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.
Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N
Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654
[TBL] [Abstract][Full Text] [Related]
17. The hamster model of sequential oral oncogenesis.
Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E
Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of Annexin A2 in oral squamous cell carcinoma.
Zhong LP; Wei KJ; Yang X; Zhang L; Zhou XJ; Pan HY; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2009 Jan; 54(1):17-25. PubMed ID: 18822406
[TBL] [Abstract][Full Text] [Related]
19. Immunoexpression of cyclooxygenase-2 and p53 in oral squamous cell carcinoma.
Goulart Filho JA; Nonaka CF; da Costa Miguel MC; de Almeida Freitas R; Galvão HC
Am J Otolaryngol; 2009; 30(2):89-94. PubMed ID: 19239949
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
